Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
On April 28, 2026, Incyte Corp (INCY) released its 8-K filing reporting first-quarter 2026 results. The company posted total GAAP revenue of $1.27 billion and n
Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer
07:00am, Tuesday, 28'th Apr 2026
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer.
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates
07:00am, Tuesday, 28'th Apr 2026
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates.
Analyzing Moleculin Biotech (NASDAQ:MBRX) and Incyte (NASDAQ:INCY)
01:28am, Monday, 27'th Apr 2026
Incyte (NASDAQ: INCY - Get Free Report) and Moleculin Biotech (NASDAQ: MBRX - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on
Incyte Gears Up to Report Q1 Earnings: What Can Investors Expect?
09:51am, Friday, 24'th Apr 2026
INCY heads into Q1 earnings with a $1.23 billion revenue view, driven by Jakafi, Opzelura, rising royalties and multiple new launches contributing to revenues.
Incyte Q1 Preview: The Growth Story Remains Intact
01:30pm, Thursday, 23'rd Apr 2026
Incyte Corporation remains a Buy despite an 8% stock decline, with a widened undervaluation and a robust non-Jakafi growth story. INCY's aggressive reinvestment supports four major product launches in
MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia
03:00am, Thursday, 23'rd Apr 2026
Minjuvi (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy
31,459 Shares in Incyte Corporation $INCY Bought by CPC Advisors LLC
04:44am, Wednesday, 22'nd Apr 2026
CPC Advisors LLC bought a new position in shares of Incyte Corporation (NASDAQ: INCY) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Tuesday, 21'st Apr 2026
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
10:00am, Tuesday, 21'st Apr 2026
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ASCO26--Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
GraniteShares Advisors LLC Buys New Holdings in Incyte Corporation $INCY
04:47am, Tuesday, 21'st Apr 2026
GraniteShares Advisors LLC bought a new stake in Incyte Corporation (NASDAQ: INCY) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commis
AE Wealth Management LLC Purchases New Holdings in Incyte Corporation $INCY
03:11am, Tuesday, 21'st Apr 2026
AE Wealth Management LLC purchased a new stake in Incyte Corporation (NASDAQ: INCY) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 26,995 shares of
Here's Why Incyte (INCY) is a Strong Value Stock
10:42am, Monday, 20'th Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Merit Financial Group LLC Has $4.92 Million Stock Holdings in Incyte Corporation $INCY
05:17am, Monday, 20'th Apr 2026
Merit Financial Group LLC increased its holdings in Incyte Corporation (NASDAQ: INCY) by 41.7% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
KBC Group NV Sells 157,700 Shares of Incyte Corporation $INCY
04:36am, Saturday, 18'th Apr 2026
KBC Group NV decreased its position in Incyte Corporation (NASDAQ: INCY) by 37.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Com
